Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Belong AI does not list a price
Free plan
Belong AI
Only Belong AI has one
Higher rating
NeuroClues
4.2 against 4.3
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Belong AI
NeuroClues
Our rating
4.2
4.3Better
Starts at
Free
Not listed
Free plan
YesBetter
No
Category
Healthcare AI
Healthcare AI
Plans
Free
See pricing
Key features
Dave: conversational AI cancer mentor validated by oncologists
Sophie: AI mentor for multiple sclerosis patients
Tara: AI clinical-trial matching by medical profile and location
Trained on seven years of patient interaction data
Free Dave Community access tier
Portable, CE-marked Class IIa medical device for clinical eye-movement recording
Calibration-free patient setup using dual infrared cameras at 400 fps
AI-derived biomarkers benchmarked against reference ranges for clinical interpretation
Early-detection targeting for Parkinson's, Alzheimer's, and multiple sclerosis
Deployment across university hospitals and private neurology practices in seven-plus countries
Pros
Medical validation from oncologists affiliated with ASCO and ESMO adds real clinical credibility
Free community tier keeps core support accessible regardless of ability to pay
Built on a decade of patient community data (Belong.Life founded 2015), not a cold-start chatbot
CE-marked Class IIa medical device status gives it real regulatory clearance, not only research-stage promise
More than €22 million raised, including a €10 million Series A, signals investor confidence
Aims at detection years before visible symptoms, where neurological treatment has the most impact
Cons
Exact DavePro subscription pricing is not published on the company site
An AI mentor cannot substitute for a patient's actual oncology care team
Sensitive health use case raises a higher bar for data-privacy scrutiny than general chatbots
No published pricing, and as a clinical device it is sold directly to institutions, not individuals
Limited so far to the European market and CE marking, without confirmed FDA clearance
As a diagnostic aid, findings still require a neurologist's clinical interpretation, not a standalone verdict
Company
Belong.Life, founded 2015
neuroClues, founded 2020
Prices come from each vendor's pricing page, last checked 20260801. Check the vendor before you buy.
FAQ
Questions people ask
Is Belong AI better than NeuroClues?
In our reviews Belong AI scores 4.2 and NeuroClues scores 4.3. The better pick depends on the job. Belong AI: AI health mentor platform that gives cancer and MS patients conversational support validated by oncologists. NeuroClues: Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis.
Belong AI
NeuroClues
